NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/03/2024
Back to search
Official data from USPTO
ESPERION THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ESPERION THERAPEUTICS
ST13
US500000075545840Class
5
Filing
75545840
Registration
2786704
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
08/03/2024
Trademark type
Word
Nice classes
5
Filing date
09/01/1998
Registration date
11/25/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2024
Last transaction
08/03/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/24/1998
First use in commerce
07/17/2002
Drawing code
1
Owner type
03
Owner location
Ann Arbor, MI
Examiner
BUSH, KAREN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Esperion Therapeutics, Inc.
Representatives
Jessica L. Rothstein GOODWIN PROCTER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of metabolic disease
Publications
History of USPTO decisions and trademark events.
51 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/15/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/25/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/09/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/09/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/09/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
11/22/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
11/22/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/30/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/30/2009
E815
TEAS SECTION 8 & 15 RECEIVED
10/16/2009
CORV
REVIEW OF CORRESPONDENCE COMPLETE
12/02/2008
PAPER RECEIVED
07/29/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/09/2003
CFIT
CASE FILE IN TICRS
08/06/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2003
PAPER RECEIVED
07/17/2003
CNRT
NON-FINAL ACTION MAILED
01/14/2003
DOCK
ASSIGNED TO EXAMINER
12/18/2002
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/10/2002
IUAF
USE AMENDMENT FILED
10/28/2002
PAPER RECEIVED
10/28/2002
EX5G
SOU EXTENSION 5 GRANTED
05/13/2002
EXT5
SOU EXTENSION 5 FILED
05/01/2002
EX4G
SOU EXTENSION 4 GRANTED
09/06/2001
EXT4
SOU EXTENSION 4 FILED
08/23/2001
EX3G
SOU EXTENSION 3 GRANTED
05/14/2001
EXT3
SOU EXTENSION 3 FILED
05/01/2001
EX2G
SOU EXTENSION 2 GRANTED
04/06/2001
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/02/2001
PETG
PETITION TO REVIVE-GRANTED
01/03/2001
EXT2
SOU EXTENSION 2 FILED
10/30/2000
EX1G
SOU EXTENSION 1 GRANTED
09/10/2000
PETR
PETITION TO REVIVE-RECEIVED
05/11/2000
EXT1
SOU EXTENSION 1 FILED
05/02/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/02/1999
PUBO
PUBLISHED FOR OPPOSITION
08/10/1999
NPUB
NOTICE OF PUBLICATION
07/11/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/1999
CNEA
EXAMINER'S AMENDMENT MAILED
04/21/1999
DOCK
ASSIGNED TO EXAMINER
04/12/1999
Continuous trademark protection
Get notified about every new filing that threatens ESPERION THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.